Search Results 661-670 of 21849 for alzheimers
... Alzheimer's. The Mayo Clinic study is published in the Feb. 27 online issue of Neurology, the medical journal of the American Academy of Neurology ...
If the scan shows reduced sugar use in the areas of the brain involved in solving problems and remembering, for example, that can be an indicator of Alzheimer's ...
Fryer, Ph.D., studies the pathogenesis of Alzheimer's disease, focusing on molecular mechanisms of known genetic risk factors. Some of these genetic risk ...
Some medications that don't work for Alzheimer's may help improve Lewy body dementia symptoms. Dr. Boeve explains it this way: In Lewy body dementia, protein ...
Ikezu strives to find disease mechanisms by using animal models that recapitulate tau pathology found in Alzheimer's disease and tauopathy in patients' brains.
... Alzheimer disease (AD) (mini-mental state examination [MMSE] 18 to 28 points ... Alzheimer's disease and related disorders association (NINCDS/ADRDA) ...
A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease. Print details. Share; Facebook · Twitter.
Clinical trials · A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease.
Gait disturbances linked with decline in cognitive function · Researchers refine guidelines designed to identify Alzheimer's early · Mayo Clinic Alzheimer's ...
Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.